Skip to main content
. 2016 Apr 18;7(18):24983–24994. doi: 10.18632/oncotarget.8804

Figure 7. PHA767491 alters the subcellular distribution of CDK942 and CDK955 in CD4+ T cells.

Figure 7

Immunofluorescence staining for changes in the expression of CDK942 and CDK955 in alloantigen-activated CD4+ T cells pretreated with PBS or 3 μM PHA767491. Scale bar: 5 mm. Cell nuclei were identified by DAPI staining (blue). PHA767491 pretreatment abrogated alloantigen-induced up-regulation of CDK942 expression, but preserved CDK955 expression. All data are representative of three independent experiments (n = 4).